Stocks · Health care · Biological Products, (No Diagnostic Substances)

Entera Bio Ltd.

ENTX Clue Score37
Israel Fiscal year ends December CIK 0001638097 Results filed 6 Nov 2026

What the insiders did Net buying

By person

15 insiders · 40 transactions

There is no salary here to measure against. Entera Bio Ltd.'s chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Sean Ellis
Director
$126.98K (6)
—
+$126.98K
208,132
$270.57K
+2,791%
Miranda Jayne Toledano
Chief Executive Officer
$112.77K (5)
—
+$112.77K
847,135
$1.10M
—
Gerald M Lieberman
Director
$97.89K (12)
—
+$97.89K
344,654
$448.05K
+194.8%
Geno J Germano
Director
$55.80K (2)
—
+$55.80K
65,014
$84.52K
+225.1%
Haya Taitel
Director
$37.58K (4)
—
+$37.58K
119,269
$155.05K
+1,490%
Dana Yaacov-Garbeli
Chief Financial Officer
$29.85K (2)
—
+$29.85K
258,172
$335.62K
+197.7%
Spiros Jamas
Chief Executive Officer
$28.50K (1)
—
+$28.50K
10,000
$13.00K
—
Gerald M Ostrov
Director
$27.38K (1)
—
+$27.38K
75,657
$98.35K
—
Phillip Schwartz
President of R&D
$25.25K (1)
—
+$25.25K
607,410
$789.63K
+1.7%
Ramesh Ratan
U.S.based CFO
$24.36K (1)
—
+$24.36K
10,000
$13.00K
—
Yonatan Malca
Director
$19.82K (1)
—
+$19.82K
100,231
$130.30K
—
Ron Mayron
Director
$19.60K (1)
—
+$19.60K
7,000
$9.10K
—
Steven D Rubin
Director
$19.45K (2)
—
+$19.45K
34,117
$44.35K
—
Gregory Burshtein
Chief of R&D
—
—
—
189,033
$245.74K
+151.6%
Hillel Galitzer
Chief Operating Officer
—
—
—
163,566
$212.64K
+379.6%

No percentages here. This company's share count has moved by a factor of 3.8 over the window, from 45,420,676 to 173,141,831 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.